According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/P28R6P
http://goo.gl/P28R6P
Wednesday 27 July 2016
According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/P28R6P
According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/P28R6P
http://goo.gl/P28R6P
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment